Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Post-operative recovery is not a limiting factor for adjuvant chemotherapy in patients undergoing surgery for colorectal cancer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. SARS-CoV-2 in saliva, oropharyngeal and nasopharyngeal specimens

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The Noergaard technique is a non-traumatic method for reduction of anterior shoulder dislocation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Characteristics of Danish children registered with and pharmacologically treated for hypertension

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Prognostic factors of 90-day mortality in patients hospitalised with COVID-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Prehabilitation in surgery - Need for new strategies?

    Publikation: Bidrag til tidsskriftLederpeer review

  2. Pleth Variability Index in Orthopedic Surgery: Comment

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  • Khadra Bashir Mohamed
  • Pia Munk-Madsen
  • Anne Fogh Juvik
  • Jens Ravn Eriksen
  • Henrik Kehlet
  • Ismail Gögenur
Vis graf over relationer

INTRODUCTION: Little is known about factors affecting the initiation of adjuvant chemotherapy (AC) after minimally invasive surgery. The aim of this study was to describe the ratio of patients undergoing uncomplicated colorectal cancer surgery in a standardised enhanced recovery after surgery setting receiving AC. Furthermore, the association between post-operative quality of recovery and initiation of AC was investigated.

METHODS: This was a prospective study. Post-operative recovery was measured with the Quality of Recovery-15 questionnaire preoperatively, post-operatively on day 1, at discharge and on post-operative day 30.

RESULTS: A total of 115 patients were included between October 2016 and May 2017. Among these, 20 patients were excluded. Hence, 95 patients were followed up as uncomplicated cases. The median length of stay was three days (interquartile range: 2-4). A total of 40 patients were referred for oncological evaluation, but nine patients did not proceed to receive AC. Among the 31 patients starting AC, 48% (n = 15) received AC less-than 4 weeks and 52% (n = 16) > 4 weeks. No significant difference was seen in post-operative quality of recovery, either when investigating the full cohort or subgroups of patients who initiated AC before and after four weeks.

CONCLUSIONS: Post-operative recovery may not be the factor limiting patients from receiving adjuvant chemotherapy either before or after post-operative week four.

FUNDING: none.

TRIAL REGISTRATION: The study was approved by the Data Protection Agency (reg. no. REG044-2018).

OriginalsprogEngelsk
ArtikelnummerA11190634
TidsskriftDanish Medical Journal
Vol/bind67
Udgave nummer10
Antal sider9
ISSN1603-9629
StatusUdgivet - 2020

Bibliografisk note

Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

ID: 61031039